Literature DB >> 10756000

Zygomycetes in human disease.

J A Ribes1, C L Vanover-Sams, D J Baker.   

Abstract

The Zygomycetes represent relatively uncommon isolates in the clinical laboratory, reflecting either environmental contaminants or, less commonly, a clinical disease called zygomycosis. There are two orders of Zygomycetes containing organisms that cause human disease, the Mucorales and the Entomophthorales. The majority of human illness is caused by the Mucorales. While disease is most commonly linked to Rhizopus spp., other organisms are also associated with human infection, including Mucor, Rhizomucor, Absidia, Apophysomyces, Saksenaea, Cunninghamella, Cokeromyces, and Syncephalastrum spp. Although Mortierella spp. do cause disease in animals, there is no longer sufficient evidence to suggest that they are true human pathogens. The spores from these molds are transmitted by inhalation, via a variety of percutaneous routes, or by ingestion of spores. Human zygomycosis caused by the Mucorales generally occurs in immunocompromised hosts as opportunistic infections. Host risk factors include diabetes mellitus, neutropenia, sustained immunosuppressive therapy, chronic prednisone use, iron chelation therapy, broad-spectrum antibiotic use, severe malnutrition, and primary breakdown in the integrity of the cutaneous barrier such as trauma, surgical wounds, needle sticks, or burns. Zygomycosis occurs only rarely in immunocompetent hosts. The disease manifestations reflect the mode of transmission, with rhinocerebral and pulmonary diseases being the most common manifestations. Cutaneous, gastrointestinal, and allergic diseases are also seen. The Mucorales are associated with angioinvasive disease, often leading to thrombosis, infarction of involved tissues, and tissue destruction mediated by a number of fungal proteases, lipases, and mycotoxins. If the diagnosis is not made early, dissemination often occurs. Therapy, if it is to be effective, must be started early and requires combinations of antifungal drugs, surgical intervention, and reversal of the underlying risk factors. The Entomophthorales are closely related to the Mucorales on the basis of sexual growth by production of zygospores and by the production of coenocytic hyphae. Despite these similarities, the Entomophthorales and Mucorales have dramatically different gross morphologies, asexual reproductive characteristics, and disease manifestations. In comparison to the floccose aerial mycelium of the Mucorales, the Entomophthorales produce a compact, glabrous mycelium. The asexually produced spores of the Entomophthorales may be passively released or actively expelled into the environment. Human disease with these organisms occurs predominantly in tropical regions, with transmission occurring by implantation of spores via minor trauma such as insect bites or by inhalation of spores into the sinuses. Conidiobolus typically infects mucocutaneous sites to produce sinusitis disease, while Basidiobolus infections occur as subcutaneous mycosis of the trunk and extremities. The Entomophthorales are true pathogens, infecting primarily immunocompetent hosts. They generally do not invade blood vessels and rarely disseminate. Occasional cases of disseminated and angioinvasive disease have recently been described, primarily in immunocompromised patients, suggesting a possible emerging role for this organism as an opportunist.

Entities:  

Mesh:

Year:  2000        PMID: 10756000      PMCID: PMC100153          DOI: 10.1128/CMR.13.2.236

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  419 in total

1.  Phycomycosis. A clinicopathologic study of fifty-one cases.

Authors:  B R STRAATSMA; L E ZIMMERMAN; J D GASS
Journal:  Lab Invest       Date:  1962-11       Impact factor: 5.662

2.  Disseminated zygomycosis (mucormycosis) caused by Saksenaea vasiformis.

Authors:  R J Hay; C K Campbell; W M Marshall; B I Rees; J Pincott
Journal:  J Infect       Date:  1983-09       Impact factor: 6.072

3.  Serological studies of a case of fatal craniofacial mucormycosis.

Authors:  R Yankey; A A Abraham
Journal:  Mycopathologia       Date:  1983-05-22       Impact factor: 2.574

4.  Subcutaneous mucormycosis caused by Saksenaea vasiformis in a thalassaemic child: first case report in Thailand.

Authors:  V S Tanphaichitr; A Chaiprasert; V Suvatte; P Thasnakorn
Journal:  Mycoses       Date:  1990-06       Impact factor: 4.377

5.  Submandibular and disseminated zygomycosis (mucormycosis) in feeder pigs.

Authors:  S E Sanford; G K Josephson; E H Waters
Journal:  J Am Vet Med Assoc       Date:  1985-01-15       Impact factor: 1.936

6.  Experimental cerebral zygomycosis in alloxan-diabetic rabbits I. Relationship of temperature tolerance of selected zygomycetes to pathogenicity.

Authors:  D J Reinhardt; W Kaplan; L Ajello
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

7.  Subcutaneous zygomycosis caused by Basidiobolus haptosporus: presentation of a case mimicking Burkitt's lymphoma.

Authors:  A L Bittencourt; G Serra; M Sadigursky; M G Araujo; M C Campos; L C Sampaio
Journal:  Am J Trop Med Hyg       Date:  1982-03       Impact factor: 2.345

Review 8.  Rhinoentomophthoromycosis: report of the first two cases observed in Costa Rica (Central America), and review of the literature.

Authors:  J J Segura; K Gonzalez; J Berrocal; G Marin
Journal:  Am J Trop Med Hyg       Date:  1981-09       Impact factor: 2.345

9.  Severe diarrhea due to Cokeromyces recurvatus in a bone marrow transplant recipient.

Authors:  O A Alvarez; J A Maples; F O Tio; M Lee
Journal:  Am J Gastroenterol       Date:  1995-08       Impact factor: 10.864

10.  Cutaneous zygomycosis caused by Absidia corymbifera in a leukemic patient.

Authors:  J O Lopes; D V Pereira; L A Streher; A A Fenalte; S H Alves; J P Benevenga
Journal:  Mycopathologia       Date:  1995-05       Impact factor: 2.574

View more
  384 in total

1.  Soft tissue infection with Absidia corymbifera in a patient with idiopathic aplastic anemia.

Authors:  R Cloughley; J Kelehan; G Corbett-Feeney; M Murray; J Callaghan; P Regan; M Cormican
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 2.  Sudden death in a patient with bone marrow transplant by a fungus among us.

Authors:  Lemuel Non; Joanna Paula Sta Cruz; Sherilyn Tuazon
Journal:  BMJ Case Rep       Date:  2014-11-12

Review 3.  The spectrum of fungi that infects humans.

Authors:  Julia R Köhler; Arturo Casadevall; John Perfect
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

4.  In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Authors:  Eric Dannaoui; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  [Classification of etiologic agents in fungal sinusitis by immunohistochemistry, histology and culture].

Authors:  K Wölke; G Jautzke; O Kaschke; B Seefeld
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

6.  Combination therapy for mucormycosis: why, what, and how?

Authors:  Brad Spellberg; Ashraf Ibrahim; Emmanuel Roilides; Russel E Lewis; Olivier Lortholary; George Petrikkos; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

7.  Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.

Authors:  Ana Alastruey-Izquierdo; Maria Victoria Castelli; Isabel Cuesta; Araceli Monzon; Manuel Cuenca-Estrella; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

8.  Mucor circinelloides as a cause of invasive maxillofacial zygomycosis: an emerging dimorphic pathogen with reduced susceptibility to posaconazole.

Authors:  Zia U Khan; Suhail Ahmad; Arnost Brazda; Rachel Chandy
Journal:  J Clin Microbiol       Date:  2009-01-26       Impact factor: 5.948

Review 9.  Advances in the diagnosis of fungal pneumonias.

Authors:  Bryan T Kelly; Kelly M Pennington; Andrew H Limper
Journal:  Expert Rev Respir Med       Date:  2020-04-21       Impact factor: 3.772

10.  Zygomycosis: an emerging fungal infection with new options for management.

Authors:  Carol A Kauffman; Anurag N Malani
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.